Patents by Inventor Chantal Alcouffe

Chantal Alcouffe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pyrazolopyridine derivatives, preparation process therefor and therapeutic use thereof
    Patent number: 10138235
    Abstract: The invention relates to FGF-inhibiting pyrazolopyrimidine derivatives of general formula (I) to a process for preparing them and to the therapeutic use thereof.
    Type: Grant
    Filed: March 7, 2017
    Date of Patent: November 27, 2018
    Assignee: SANOFI
    Inventors: Chantal Alcouffe, Kirsten Bjegarde, Jacques Mauger
  • Pyrazolopyridine Derivatives, Preparation Process Therefor And Therapeutic Use Thereof
    Publication number: 20170231998
    Abstract: The invention relates to FGF-inhibiting pyrazolopyrimidine derivatives of general formula (I) to a process for preparing them and to the therapeutic use thereof.
    Type: Application
    Filed: March 7, 2017
    Publication date: August 17, 2017
    Inventors: Chantal ALCOUFFE, Kirsten BJEGARDE, Jacques MAUGER
  • Therapeutic use of imidazopyridine derivatives
    Patent number: 9732078
    Abstract: The invention relates to the use of compounds corresponding to formula (I) in which R2 and R3 together form, with the carbon atoms of the phenyl nucleus to which they are attached, a 6-membered nitrogenous heterocycle corresponding to one of the formulae (A), (B) and (C) in which the wavy lines represent the phenyl nucleus to which R2 and R3 are attached, or of a pharmaceutically acceptable salt thereof, for preparing a medicament for the treatment of bladder cancer.
    Type: Grant
    Filed: January 3, 2013
    Date of Patent: August 15, 2017
    Assignee: SANOFI
    Inventors: Chantal Alcouffe, Corentin Herbert
  • Pyrazolopyridine Derivatives, Preparation Process Therefor And Therapeutic Use Thereof
    Publication number: 20170174681
    Abstract: The invention relates to FGF-inhibiting pyrazolopyrimidine derivatives of general formula (I) to a process for preparing them and to the therapeutic use thereof.
    Type: Application
    Filed: March 7, 2017
    Publication date: June 22, 2017
    Inventors: Chantal ALCOUFFE, Kirsten BJEGARDE, Jacques MAUGER
  • Pyrazolopyridine derivatives for use in the treatment of bladder cancer
    Patent number: 9572799
    Abstract: The invention relates to the use of compounds corresponding to formula (I), or a pharmaceutically acceptable salt thereof, for preparing a medicament for the treatment of bladder cancer.
    Type: Grant
    Filed: June 13, 2014
    Date of Patent: February 21, 2017
    Assignee: SANOFI
    Inventor: Chantal Alcouffe
  • Imidazopyridine derivatives, process for preparation thereof and therapeutic use thereof
    Patent number: 9452164
    Abstract: The invention relates to compounds corresponding to formula (I): in which R2 and R3 together form, with the carbon atoms of the phenyl nucleus to which they are attached, a 6-membered nitrogenous heterocycle corresponding to one of formula (A), (B) or (C) below: in which the wavy lines represent the phenyl nucleus to which R2 and R3 are attached. Preparation process and therapeutic use.
    Type: Grant
    Filed: May 1, 2014
    Date of Patent: September 27, 2016
    Assignee: SANOFI
    Inventors: Chantal Alcouffe, Reinhard Kirsch, Corentin Herbert, Gilbert Lassalle
  • PYRAZOLOPYRIDINE DERIVATIVES FOR USE IN THE TREATMENT OF BLADDER CANCER
    Publication number: 20160128989
    Abstract: The invention relates to the use of compounds corresponding to formula (I), or a pharmaceutically acceptable salt thereof, for preparing a medicament for the treatment of bladder cancer.
    Type: Application
    Filed: June 13, 2014
    Publication date: May 12, 2016
    Inventor: Chantal ALCOUFFE
  • Pyrazolopyridine Derivatives, Preparation Process Therefor And Therapeutic Use Thereof
    Publication number: 20140350006
    Abstract: The invention relates to FGF-inhibiting pyrazolopyrimidine derivatives of general formula (I) to a process for preparing them and to the therapeutic use thereof.
    Type: Application
    Filed: December 13, 2012
    Publication date: November 27, 2014
    Inventors: Chantal Alcouffe, Kirsten Bjegarde, Jacques Mauger
  • Therapeutic Use of Imidazopyridine Derivatives
    Publication number: 20140343054
    Abstract: The invention relates to the use of compounds corresponding to formula (I) in which R2 and R3 together form, with the carbon atoms of the phenyl nucleus to which they are attached, a 6-membered nitrogenous heterocycle corresponding to one of the formulae (A), (B) and (C) in which the wavy lines represent the phenyl nucleus to which R2 and R3 are attached, or of a pharmaceutically acceptable salt thereof, for preparing a medicament for the treatment of bladder cancer.
    Type: Application
    Filed: January 3, 2013
    Publication date: November 20, 2014
    Inventors: Chantal Alcouffe, Corentin Herbert
  • Indolizine derivatives, process for the preparation thereof and therapeutic use thereof
    Patent number: 8859544
    Abstract: The invention relates to compounds corresponding to formula (I): in which R3 and R4 together form, with the carbon atoms of the phenyl nucleus to which they are attached, a 6-membered nitrogenous heterocycle corresponding to one of formula (A), (B) or (C) below: in which the wavy lines represent the phenyl nucleus to which R3 and R4 are attached. Preparation process and therapeutic use.
    Type: Grant
    Filed: July 4, 2011
    Date of Patent: October 14, 2014
    Assignee: Sanofi
    Inventors: Chantal Alcouffe, Corentin Herbert, Gilbert Lassalle
  • IMIDAZOPYRIDINE DERIVATIVES, PROCESS FOR PREPARATION THEREOF AND THERAPEUTIC USE THEREOF
    Publication number: 20140243328
    Abstract: The invention relates to compounds corresponding to formula (I): in which R2 and R3 together form, with the carbon atoms of the phenyl nucleus to which they are attached, a 6-membered nitrogenous heterocycle corresponding to one of formula (A), (B) or (C) below: in which the wavy lines represent the phenyl nucleus to which R2 and R3 are attached. Preparation process and therapeutic use.
    Type: Application
    Filed: May 1, 2014
    Publication date: August 28, 2014
    Applicant: SANOFI
    Inventors: Chantal ALCOUFFE, Reinhard KIRSCH, Corentin HERBERT, Gilbert LASSALLE
  • Imidazopyridine derivatives, process for preparation thereof and therapeutic use thereof
    Patent number: 8759344
    Abstract: The invention relates to compounds corresponding to formula (I): in which R2 and R3 together form, with the carbon atoms of the phenyl nucleus to which they are attached, a 6-membered nitrogenous heterocycle corresponding to one of formula (A), (B) or (C) below: in which the wavy lines represent the phenyl nucleus to which R2 and R3 are attached. Preparation process and therapeutic use.
    Type: Grant
    Filed: July 4, 2011
    Date of Patent: June 24, 2014
    Assignee: Sanofi
    Inventors: Chantal Alcouffe, Reinhard Kirsch, Corentin Herbert, Gilbert Lassalle
  • Imidazo[1,5-a]pyridine derivatives, method for preparing same and pharmaceutical compositions containing same
    Patent number: 8633216
    Abstract: The invention concerns compounds of formula I, a method for preparing said compounds, pharmaceutical compositions containing same and the therapeutic uses thereof.
    Type: Grant
    Filed: February 4, 2011
    Date of Patent: January 21, 2014
    Assignee: Sanofi
    Inventors: Chantal Alcouffe, Alain Badorc, Francoise Bono, Marie-Francoise Bordes
  • IMIDAZOPYRIDINE DERIVATIVES, PROCESS FOR PREPARATION THEREOF AND THERAPEUTIC USE THEREOF
    Publication number: 20130116250
    Abstract: The invention relates to compounds corresponding to formula (I): in which R2 and R3 together form, with the carbon atoms of the phenyl nucleus to which they are attached, a 6-membered nitrogenous heterocycle corresponding to one of formula (A), (B) or (C) below: in which the wavy lines represent the phenyl nucleus to which R2 and R3 are attached. Preparation process and therapeutic use.
    Type: Application
    Filed: July 4, 2011
    Publication date: May 9, 2013
    Applicant: SANOFI
    Inventors: Chantal Alcouffe, Reinhard Kirsch, Corentin Herbert, Gilbert Lassalle
  • INDOLIZINE DERIVATIVES, PROCESS FOR THE PREPARATION THEREOF AND THERAPEUTIC USE THEREOF
    Publication number: 20130116249
    Abstract: The invention relates to compounds corresponding to formula (I): in which R3 and R4 together form, with the carbon atoms of the phenyl nucleus to which they are attached, a 6-membered nitrogenous heterocycle corresponding to one of formula (A), (B) or (C) below: in which the wavy lines represent the phenyl nucleus to which R3 and R4 are attached. Preparation process and therapeutic use.
    Type: Application
    Filed: July 4, 2011
    Publication date: May 9, 2013
    Applicant: SANOFI
    Inventors: Chantal Alcouffe, Corentin Herbert, Gilbert Lassalle
  • Imidazo[1,5-a] pyridine derivatives, method for preparing same and pharmaceutical compositions containing same
    Patent number: 8008321
    Abstract: The invention concerns compounds of formula I, a method for preparing said compounds, pharmaceutical compositions containing same and the therapeutic uses thereof.
    Type: Grant
    Filed: September 14, 2007
    Date of Patent: August 30, 2011
    Assignee: Sanofi-Aventis
    Inventors: Chantal Alcouffe, Alain Badorc, Francoise Bono, Marie-Francoise Bordes
  • Novel imidazo[1,5-a]pyridine derivatives, method for preparing same and pharmaceutical compositions containing same
    Publication number: 20110136856
    Abstract: The invention concerns compounds of formula I, a method for preparing said compounds, pharmaceutical compositions containing same and the theraprutic uses thereof.
    Type: Application
    Filed: February 4, 2011
    Publication date: June 9, 2011
    Applicant: SANOFI-AVENTIS
    Inventors: Chantal ALCOUFFE, Alain BADORC, Francoise BONO, Marie-Francoise BORDES
  • Substituted indolizine 1,2,3,6,7,8 derivatives, FGFs inhibitors, a method for the preparation thereof and pharmaceutical compositions containing said derivatives
    Patent number: 7553845
    Abstract: The invention is directed to a compound of formula I, wherein R, R1, R2, R3 and R4 are as defined herein, or a pharmaceutically acceptable salt thereof, and its pharmaceutically composition, preparation and uses as an inhibitor of FGFs (fibroblast growth factors).
    Type: Grant
    Filed: March 17, 2006
    Date of Patent: June 30, 2009
    Assignee: sanofi-aventis
    Inventors: Chantal Alcouffe, Alain Badorc, Francoise Bono, Marie-Francoise Bordes, Nathalie Guillo, Jean-Marc Herbert
  • Novel imidazo[1,5-a] pyridine derivatives, method for preparing same and pharmaceutical compositions containing same
    Publication number: 20080108648
    Abstract: The invention concerns compounds of formula I, a method for preparing said compounds, pharmaceutical compositions containing same and the therapeutic uses thereof.
    Type: Application
    Filed: September 14, 2007
    Publication date: May 8, 2008
    Applicant: sanofi-aventis
    Inventors: Chantal ALCOUFFE, Alain Badorc, Francoise Bono, Marie-Francoise Bordes
  • Substituted indolizine 1,2,3,6,7,8 derivatives, FGFs inhibitors, a method for the preparation thereof and pharmaceutical compositions containing said derivatives
    Publication number: 20060199962
    Abstract: The invention is directed to a compound of formula I, wherein R, R1, R2, R3 and R4 are as defined herein, or a pharmaceutically acceptable salt thereof, and its pharmaceutically composition, preparation and uses as an inhibitor of FGFs (fibroblast growth factors).
    Type: Application
    Filed: March 17, 2006
    Publication date: September 7, 2006
    Applicant: Sanofi-aventis
    Inventors: Chantal Alcouffe, Alain Badorc, Francoise Bono, Marie-Francoise Bordes, Nathalie Guillo, Jean-Marc Herbert